Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies
Clinical trial NCT05006794 · TERMINATED
Trial details
- NCT number
- NCT05006794
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-15
- Primary completion
- 2025-06-16
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.